Skip to main content
NSP $52.20 -2.92%
NSP logo

NSP · Insperity, Inc.

Track NSP — free
$52.20 -1.57 (-2.92%) At close · Aug 14
Market Cap
$1.92B
Shares
38.20M
All earnings calls

Earnings call · FY2026 Q1

Insperity, Inc. Q1 FY2026 Earnings Call

Insperity, Inc. Q1 FY2026 Earnings Call

Concluded Apr 30, 2026 Audio replay
Apr 30, 2026 55:36 43 turns
Period
FY2026 Q1
Runtime
55:36
Sources
4 artifacts

Executive readout · one minute

What matters this quarter

Insperity reported Q1 2026 adjusted EPS of $1.31 and adjusted EBITDA of $103 million, with gross profit down 3% (an improvement from the 21% decline in Q4 2025), but the company lowered its full-year 2026 guidance, citing weaker sales, retention and net hiring.

HRScale product rollout 42 Margin recovery plan 36 Benefit costs and pricing 29 Growth momentum and worksite employees 23 Restructuring and operating expenses 8 Capital allocation and balance sheet 5

Management tone

Positive

Net tone +15 · moderate hedging

Grounding quotes
  • “We are pleased with the progress of our margin recovery plan and the lower-than-expected Q1 benefits cost.”
  • “we remain cautious about the range of potential outcomes for the remainder of the year”
  • “Booked sales came in below our internal targets, except for our three HR360 mid-market sales.”
  • “we still have very strong conviction about our recovery for the full year.”

Forward guidance

2 guided metrics

Management's latest ranges and targets are included below.

Research coverage

4 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $1.90B +1.7% YoY
Diluted EPS $0.88 -34.8% YoY
Gross margin 15.9% -0.7 pp YoY
Net income $33.00M -35.3% YoY

Research materials

Open the source you need; every reader stays inside this workspace.

Key takeaways

What improved, and what deserves a closer read.

Constructive signals

  • Gross profit decline improved to 3% in Q1 2026 from a 21% decline in Q4 2025, reflecting progress on the margin recovery plan.
  • Adjusted EBITDA of $103 million was 1% higher than Q1 2025's $102 million, with CEO calling Q1 earnings 'strong'.
  • Benefit cost per covered employee rose 5% over Q1 2025, an improvement from the 9% level encountered throughout 2025.
  • Operating expenses decreased 5% excluding the $9 million restructuring charge, versus Q1 2025.
  • Lower-than-expected benefit costs were driven by favorable runoff of prior period claims, reduced large claim activity and lower-than-expected pharmacy claims.
  • Management expects margin recovery to be 'substantially full' moving into 2027, and the new UnitedHealthcare contract is anticipated to add earnings later in the year.

Risks & pressure points

  • Average paid WSEEs of 303,049 declined 1% versus Q1 2025, with worksite employees from new client sales down 7%.
  • Client attrition of 11% remained within the historical 9%–12% range, and booked sales came in below internal targets in Q1.
  • Adjusted EPS of $1.31 was 17% lower than the $1.57 reported in Q1 2025, partly due to a 41% effective tax rate versus 29% in Q1 2025.
  • Full-year 2026 adjusted EPS guidance was lowered to a range of $1.60–$2.60, with average WSEEs now expected to decline 2.3% to 1.0%, reflecting lower starting point and weaker-than-expected sales, retention and net hiring.
  • Q1 2026 included a $9 million restructuring charge tied to a recent workforce realignment.
  • Macro sentiment in the SMB sector and the impact of pricing/client-selection actions were cited as headwinds to growth across sales, retention and net hiring.

Key moments

Jump directly to management's words in the synchronized transcript.

“It is important to note that the new UnitedHealthcare contract is anticipated to have a positive impact of helping to flatten our quarterly earnings pattern starting this year with less expected earnings early in the year and more expected earnings later in the year.” Speaker 1, CFO

Forward guidance

From the 8-K filed Apr 30, 2026.

Metric Guided
Adjusted EPS table
Q2 2026
$0.02 – $0.50
Adjusted EPS table
Full Year 2026
$1.60 – $2.60

Quarter detail

How the reported period landed and where the business moved.

Revenue · regions

Northeast$527.00M +0.2% YoY
West$386.00M +2.4% YoY
Southwest$350.00M +0.9% YoY
Central$342.00M +2.1% YoY
Southeast$271.00M +5.4% YoY
Other Revenues$19.00M -9.5% YoY

Capital returned

Buybacks
$4.00M
Shares repurchased
Dividend / share
$0.60
Full-screen source Call document